Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Nov;122(5):1461-1478.
doi: 10.1016/j.ajcnut.2025.09.012. Epub 2025 Sep 10.

Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: a meta-analysis of randomized trials

Affiliations
Meta-Analysis

Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: a meta-analysis of randomized trials

Shuo Feng et al. Am J Clin Nutr. 2025 Nov.

Abstract

Background: Carbohydrate-restricted diets (CRDs) are widely promoted for improving cardiovascular and body composition outcomes, yet evidence remains mixed across dietary patterns, populations, and study designs.

Objectives: This meta-analysis evaluated the effects of CRDs on cardiovascular and anthropometric outcomes and examined whether these effects varied by diet type, macronutrient replacement, participant characteristics, and study features.

Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, 174 randomized trials (n = 11,481) from 27 countries were included. Eligible studies compared CRDs (≤45% of energy from carbohydrates) to higher-carbohydrate diets in adults and reported cardiovascular or anthropometric outcomes. Random-effects models estimated standardized mean differences (SMDs) and 95% confidence intervals (CIs). Subgroup analyses explored differences by CRD type (ketogenic, low-carb, and moderate-carb), replacement macronutrient (fat, protein, or combination), sex, weight status, diabetes status, intervention delivery, caloric intakes, and study design. Metaregressions assessed the effects of intervention duration.

Results: CRDs significantly reduced triglycerides [SMD: -15.11 mg/dL; 95% CI: -18.76, -11.46], systolic (SMD: -2.05 mmHg; 95% CI: -3.13, -0.96) and diastolic blood pressure (SMD: -1.26 mmHg; 95% CI: -1.94, -0.57), various lipid profile ratios, and inflammatory markers (C-reactive protein, tumor necrosis factor-alpha), whereas increasing high-density lipoprotein (SMD: 2.92 mg/dL, 95% CI: 2.10, 3.74). Low-density lipoprotein (LDL) and total cholesterol increased modestly (SMD: 4.81, 95% CI: 2.58, 7.05; and SMD: 4.32 mg/dL, 95% CI: 1.66, 6.97, respectively). All measured body composition markers showed significant reductions. Moderate-carbohydrate diets offered balanced benefits, whereas ketogenic diets produced greater weight loss but greater increases in LDL and total cholesterol. Combined fat and protein replacements yielded the most comprehensive improvements. Benefits were most pronounced in females and individuals with overweight or obesity. Longer interventions amplified effects on lipid ratios and inflammatory markers.

Conclusions: CRDs improved cardiovascular health and body composition, especially in diets with combined macronutrient replacement. Potential adverse effects, including LDL elevation and lean mass loss, warrant clinical monitoring.

Trial registration number: for body composition, PROSPERO: CRD420251043066 (https://www.crd.york.ac.uk/PROSPERO/view/CRD420251043066); for cardiovascular health: CRD420251011748 (https://www.crd.york.ac.uk/PROSPERO/view/CRD420251011748).

Keywords: body composition; carbohydrate-restricted diets; cardiovascular health; inflammatory markers; lipid profiles; macronutrient replacement; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA diagram. ERIC stands for Education Resources Information Center.

References

    1. WHO, Cardiovascular diseases (CVDs), 2021 Updated July 31, 2025. Accessed August 20, 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases....
    1. Emerging Risk Factors Collaboration, Wormser D., Kaptoge S., Di Angelantonio E., Wood A.M., Pennells L., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–1095. - PMC - PubMed
    1. World Health Organization . 2025. Obesity and overweight.
    1. Okunogbe A., Nugent R., Spencer G., Powis J., Ralston J., Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob. Health. 2022;7(9)
    1. Kossoff E.H., Zupec-Kania B.A., Auvin S., Ballaban-Gil K.R., Christina Bergqvist A.G., Blackford R., et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175–192. - PMC - PubMed

LinkOut - more resources